Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.61%700.92K | -36.96%371.6K | -33.60%429.14K | 126.32%2.33M | -0.32%558.62K | 25.29%536.67K | 1,328.42%589.47K | 646.27K | -3.81%1.03M | 327.13%560.39K |
| Operating revenue | 30.61%700.92K | -36.96%371.6K | -33.60%429.14K | 126.32%2.33M | -0.32%558.62K | 25.29%536.67K | 1,328.42%589.47K | --646.27K | -3.81%1.03M | 327.13%560.39K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -24.95%728.5K | -19.27%626.47K | -9.20%734.89K | 4.92%3.23M | 14.44%676.16K | 14.56%970.69K | -8.41%775.97K | 1.77%809.33K | -47.04%3.08M | -50.89%590.84K |
| Selling and administrative expenses | -57.98%185.38K | -36.68%177.17K | -31.34%181.07K | -40.75%1.02M | -78.78%32.92K | 6.36%441.11K | -52.71%279.78K | -52.56%263.74K | -62.40%1.72M | -81.22%155.15K |
| -General and administrative expense | -57.98%185.38K | -36.68%177.17K | -31.34%181.07K | -40.75%1.02M | -78.78%32.92K | 6.36%441.11K | -52.71%279.78K | -52.56%263.74K | -62.40%1.72M | -81.22%155.15K |
| Research and development costs | --16.55K | --0 | --30.09K | 896.16%91.77K | --91.77K | --0 | --0 | --0 | -97.75%9.21K | --0 |
| Depreciation amortization depletion | 0.00%80.46K | 8.90%89.15K | -3.94%80.46K | 16.02%343.46K | 10.69%97.38K | 11.27%80.46K | 17.91%81.86K | 26.27%83.76K | 11.13%296.05K | 11.13%87.97K |
| -Depreciation and amortization | 0.00%80.46K | 8.90%89.15K | -3.94%80.46K | 16.02%343.46K | 10.69%97.38K | 11.27%80.46K | 17.91%81.86K | 26.27%83.76K | 11.13%296.05K | 11.13%87.97K |
| Other operating expenses | -0.67%446.11K | -13.07%360.16K | -4.02%443.27K | 68.18%1.78M | 30.59%454.09K | 24.67%449.11K | 122.49%414.33K | 181.89%461.84K | 84.44%1.06M | 98.73%347.72K |
| Operating profit | 93.65%-27.58K | -36.66%-254.87K | -87.50%-305.75K | 56.06%-901.11K | -285.98%-117.53K | -3.59%-434.02K | 76.86%-186.5K | 79.50%-163.07K | 56.79%-2.05M | 97.16%-30.45K |
| Net non-operating interest income (expenses) | 4.72%-38.62K | 11.54%-36.55K | 7.10%-40.86K | -6.55%-163.26K | -146.44%-37.43K | 26.16%-40.53K | -13.41%-41.32K | 5.85%-43.98K | -126.19%-153.22K | -26.34%-15.19K |
| Non-operating interest income | ---- | ---- | ---- | --5.69K | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-operating interest expense | -4.72%38.62K | -11.54%36.55K | -7.10%40.86K | 43.02%168.95K | 316.61%43.12K | -26.16%40.53K | 13.41%41.32K | -5.85%43.98K | 74.38%118.13K | -265.58%-19.91K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --35.1K | ---- |
| Other net income (expenses) | -331.32%-13K | -429.36%-987.21K | -170.50%-604.19K | -2,948.86%-387.85K | -88.66%5.62K | -2,060.98%-804 | 96.72%-186.49K | 92.12%-223.36K | ||
| Special income (charges) | --0 | ---- | ---- | -470.28%-987.21K | -174.74%-627.21K | -10,240.85%-360K | ---- | ---- | 96.88%-173.11K | 91.56%-228.3K |
| -Less:Impairment of capital assets | --0 | ---- | ---- | 173.39%984.19K | 316.13%624.19K | --360K | ---- | ---- | -86.70%360K | -94.46%150K |
| -Less:Other special charges | ---- | ---- | ---- | 101.62%3.02K | -88.96%8.64K | ---- | ---- | ---- | ---186.89K | --78.3K |
| Other non-operating income (expenses) | ---- | -331.32%-13K | ---- | ---- | ---- | -71.13%-27.85K | 368.64%5.62K | -2,060.98%-804 | 89.51%-13.38K | --4.94K |
| Income before tax | 92.32%-66.2K | -37.00%-304.42K | -66.76%-346.61K | 14.17%-2.05M | -182.22%-759.15K | -77.23%-862.39K | 71.97%-222.2K | 75.31%-207.85K | 77.23%-2.39M | 93.13%-269K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 92.32%-66.2K | -37.00%-304.42K | -66.76%-346.61K | 14.17%-2.05M | -182.22%-759.15K | -77.23%-862.39K | 71.97%-222.2K | 75.31%-207.85K | 77.23%-2.39M | 93.13%-269K |
| Net income continuous operations | 92.32%-66.2K | -37.00%-304.42K | -66.76%-346.61K | 14.17%-2.05M | -182.22%-759.15K | -77.23%-862.39K | 71.97%-222.2K | 75.31%-207.85K | 77.23%-2.39M | 93.13%-269K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 92.32%-66.2K | -37.00%-304.42K | -66.76%-346.61K | 14.17%-2.05M | -182.22%-759.15K | -77.23%-862.39K | 71.97%-222.2K | 75.31%-207.85K | 77.23%-2.39M | 93.13%-269K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 92.32%-66.2K | -37.00%-304.42K | -66.76%-346.61K | 14.17%-2.05M | -182.22%-759.15K | -77.23%-862.39K | 71.97%-222.2K | 75.31%-207.85K | 77.23%-2.39M | 93.13%-269K |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.02 | 0 | 0 | 0 | 83.33%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.02 | 0 | 0 | 0 | 83.33%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.